Interestingly, evidence has demonstrated that ABHD11-AS1 is closely correlated with an unfavorable prognosis of patients with non–small-cell lung cancer (27), bladder cancer (28, 29), ovarian cancer (30), thyroid cancer (31, 32), and other cancers, but ABHD11-AS1 was first confirmed to have an association with breast cancer prognosis in this study. Here, ABHD11 is linked to ovarian cancer.